Immunosuppression as a risk factor for COVID-19: a meta-analysis.

Daniel TassoneAlexander ThompsonWilliam ConnellTanya LeeRyan UngaroPing AnYijuan DingNik S Ding

Published in: Internal medicine journal (2021)

Compared to the general population, immunosuppressed patients were not at significantly increased risk of COVID-19 infection. This finding provides support for current expert consensus statements, which have recommended the continuation of immunosuppressant therapy in the absence of COVID-19.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
stem cells